Prognostic factors in carcinomas of unknown primary site

被引:0
|
作者
Seve, P. [2 ,3 ]
Culine, S. [1 ]
机构
[1] CHU Henri Mondor, Med Oncol Serv, F-94010 Creteil, France
[2] Hosp Civils Lyon, Serv Med Interne, F-69288 Lyon 02, France
[3] Univ Lyon 1, Fac Med Lyon Sud, F-69622 Villeurbanne, France
关键词
Carcinoma of unknown primary (CUP); Prognostic factors;
D O I
10.1007/s10269-008-0970-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinomas of unknown primary (CUP) site are a heterogeneous group of tumours with widely variable natural histories and poor survival rates. In a minority of patients, the clinical presentation similar to that of known primar cancers at an equivalent stage has resulted in the identification of subsets of patients with favourable clinical and pathological features. Their recognition is of major importance since specific management may prolong survival. For the vast majority of patients with CUP however, the identification of reliable prognostic indicators has proven challenging. A number of studies with multivariate analyses identified poor performance status, liver metastases, abnormal serum lacticodehydrogenase levels, and low serum albumin as main recurrent adverse prognostic factors. Adequate knowledge of prognostic factors may help oncologists in refining the daily management of patients, assessing the results and designing clinical research studies.
引用
收藏
页码:703 / 706
页数:4
相关论文
共 50 条
  • [1] Prognostic factors for treatment results in patients with carcinoma unknown primary site (CUPS)
    Jentsch-Ullrich, K
    Leuner, S
    Kahl, C
    Arland, R
    Florschutz, A
    Franke, A
    Hoffkes, HG
    CANCER JOURNAL - FRANCE, 1998, 11 (04): : 196 - 200
  • [2] Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site
    Seve, Pascal
    Ray-Coquard, Isabelle
    Trillet-Lenoir, Veronique
    Sawyer, Michael
    Hanson, John
    Broussolle, Christiane
    Negrier, Sylvie
    Dumontet, Charles
    Mackey, John R.
    CANCER, 2006, 107 (11) : 2698 - 2705
  • [3] Cervical squamous cell carcinoma of unknown primary: Oncological outcomes and prognostic factors
    Meulemans, Jeroen
    Voortmans, Jens
    Nuyts, Sandra
    Daisne, Jean-Francois
    Clement, Paul
    Laenen, Annouschka
    Delaere, Pierre
    Van Lierde, Charlotte
    Vander Poorten, Vincent
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Carcinoma of unknown primary site. Entity - epidemiology - prognosis - risk factors
    Stahl, Michael
    ONKOLOGE, 2017, 23 (12): : 974 - 980
  • [5] LIVER METASTASES OF UNKNOWN PRIMARY SITE
    MOUSSEAU, M
    SCHAERER, R
    LUTZ, JM
    MENEGOZ, F
    FAURE, H
    SWIERCZ, P
    BULLETIN DU CANCER, 1991, 78 (08) : 725 - 736
  • [6] Neuroendocrine Carcinoma of Unknown Primary Site
    Spigel, David R.
    Hainsworth, John D.
    Greco, F. Anthony
    SEMINARS IN ONCOLOGY, 2009, 36 (01) : 52 - 59
  • [7] New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis
    Trivanovic, D.
    Petkovic, M.
    Stimac, D.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 43 - 48
  • [8] Carcinomas of an unknown primary origin-diagnosis and treatment
    Massard, Christophe
    Loriot, Yohann
    Fizazi, Karim
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (12) : 701 - 710
  • [9] Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
    Dahl, Mary
    Aurit, Sarah J.
    Silberstein, Peter T.
    Gootee, Jonathan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [10] Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables
    J. Ponce Lorenzo
    A. Segura Huerta
    R. Díaz Beveridge
    A. Giménez Ortiz
    F. Aparisi Aparisi
    T. Fleitas Kanonnikoff
    P. Richart Aznar
    H. de la Cueva Sapiña
    J. Montalar Salcedo
    Clinical and Translational Oncology, 2007, 9 : 452 - 458